
Bdrelin 3.75mg Injection
Marketer
BDR Pharmaceuticals Internationals Pvt
Salt Composition
Triptorelin (3.75mg)
Overview Bdrelin 3.75mg Injection
Triptorelin 3.75mg Injection treats prostate cancer, endometriosis (excessive uterine lining growth causing pain, heavy/irregular periods), and central precocious puberty (premature puberty). Administered subcutaneously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Follow your doctor's instructions precisely; incorrect usage or overdose can lead to serious adverse effects. Benefits may not be apparent for weeks or months; discontinue only as directed. Common side effects include hot flushes, weakness, diaphoresis, lethargy, backache, and impotence. Prolonged use can weaken bones, reducing bone mineral density; calcium and vitamin D supplementation is recommended. Amenorrhea (absence of menstruation) for 7-12 weeks is possible; report persistent bleeding. Inform your doctor of alcohol consumption, smoking, and osteoporosis before starting treatment. Disclose all medications to your healthcare provider due to potential interactions. This injection is contraindicated during pregnancy and breastfeeding; reliable contraception is crucial for both partners during treatment.
Uses of Bdrelin 3.75mg Injection
Malignant prostate tumor|Uterine endometriosis|Early-onset puberty
Major Benefits of Bdrelin 3.75mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Bdrelin 3.75mg Injection:
- Weakness
- Increased sweating
- Back pain
- Paresthesia (tingling or pricking sensation)
- Hot flashes
- Erectile dysfunction
How to use Bdrelin 3.75mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Bdrelin 3.75mg Injection works:
Bdrelin 3.75mg Injection lowers sex hormone production, specifically testosterone in men and estrogen in women. Its mechanism involves reducing circulating testosterone in males. In females, it suppresses ovarian hormone synthesis, thus decreasing estrogen levels and impacting menstruation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Bdrelin 3.75mg Injection may pose safety risks; seek medical advice before combining them.
PregnancyUNSAFE
Administration of Bdrelin 3.75mg Injection is strongly contraindicated during pregnancy. Pregnant individuals should consult their physician; research in animal and human studies reveals substantial adverse consequences for fetal development.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Bdrelin 3.75mg Injection with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Administering Bdrelin 3.75mg Injection might result in adverse reactions impacting driving capabilities. Potential side effects include dizziness, fatigue, and visual disturbances like blurred vision, all of which can impair driving skills.
KidneyCAUTION
Individuals with kidney impairment should use Bdrelin 3.75mg Injection cautiously. A modified dosage of Bdrelin 3.75mg Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should use Bdrelin 3.75mg Injection cautiously. Dosage modification of Bdrelin 3.75mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Bdrelin 3.75mg Injection :
Should you forget a Bdrelin 3.75mg Injection, seek your physician's advice.
Facts to Know About Bdrelin 3.75mg Injection
Label | Value |
---|---|
Type of Compound | Short-chain amino acid sequences |
Potential for Dependence | None. |
Type of Treatment | Endocrine secretions |
Mechanism of Action | Gonadotropin-releasing hormone agonists or analogs |